SIMBRINZA 2 mg/mL
brinzolamide/brimonidine tartrate · SUSPENSION/ DROPS · Alcon Laboratories, Inc.
SIMBRINZA is a suspension/ drops containing brinzolamide/brimonidine tartrate at 2 mg/mL, taken ophthalmic. Manufactured by Alcon Laboratories, Inc..
Key Facts
- Brand Name
- SIMBRINZA
- Generic Name
- brinzolamide/brimonidine tartrate
- NDC Code (Product)
0065-4147- Manufacturer
- Alcon Laboratories, Inc.
- Strength
- 2 mg/mL
- Dosage Form
- SUSPENSION/ DROPS
- Route
- OPHTHALMIC
- Marketing Status
- Application #
- NDA204251
- Drug Class
- Carbonic Anhydrase Inhibitor [EPC]
- Marketing Start
- 05/06/2013
Recall History
No Recall HistoryFrequently Asked Questions
What is SIMBRINZA used for?
SIMBRINZA contains brinzolamide/brimonidine tartrate. It is a suspension/ drops taken ophthalmic. Consult your doctor for specific uses.
Is SIMBRINZA a controlled substance?
SIMBRINZA is not classified as a controlled substance by the DEA.
What is the generic name for SIMBRINZA?
The generic name for SIMBRINZA is brinzolamide/brimonidine tartrate. There are no other listed brand versions of brinzolamide/brimonidine tartrate.
What is the NDC code for SIMBRINZA 2 mg/mL?
The NDC (National Drug Code) for SIMBRINZA 2 mg/mL is 0065-4147, listed by Alcon Laboratories, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)